|Title:||Professor of Neurology (Neuroscience)|
|Advanced Degrees:||Ph.D., neurobiology, Harvard|
|Affiliation:||Massachusetts General Hospital|
|Department:||Genetics and Aging Research Unit, Director|
Member reports the following financial or other potential conflicts of interest: [Last Modified: 12 July 2009]
Co-founder and shareholder in Neurogenetic Pharmaceuticals and Prana Biotechnology. Consultant to Eisai, Seimens, Pathway Genomics, Neurogenetic Pharmaceuticals, and Prana Biotechnology.